kabutan

SHIN NIPPON BIOMEDICAL LABORATORIES, LTD.(2395) Summary

2395
TSE Prime
SHIN NIPPON BIOMEDICAL LABORATORIES, LTD.
1,839
JPY
-18
(-0.97%)
Dec 5, 12:47 pm JST
11.85
USD
Dec 4, 10:47 pm EST
Result
PTS
outside of trading hours
1,837
Dec 5, 12:46 pm JST
Summary Chart Historical News Financial Result
PER
21.5
PBR
2.02
Yield
2.72%
Margin Trading Ratio
5.83
Stock Price
Dec 5, 2025
Opening Dec 5, 9:00 am
1,829 JPY 11.79 USD
Previous Close Dec 4
1,857 JPY 11.95 USD
High Dec 5, 9:01 am
1,855 JPY 11.95 USD
Low Dec 5, 9:03 am
1,827 JPY 11.77 USD
Volume
89,300
Trading Value
0.16B JPY 1.06M USD
VWAP
1839.41 JPY 11.86 USD
Minimum Trading Value
183,900 JPY 1,185 USD
Market Cap
0.08T JPY 0.49B USD
Number of Trades
395
Liquidity & Number of Trades
As of Dec 5, 2025
Liquidity
Slightly High
1-Year Average
921
1-Year High May 1, 2025
5,267
Margin Trading
Date Short Interest Long Margin Positions Ratio
Nov 28, 2025 56,400 714,800 12.67
Nov 21, 2025 36,400 804,900 22.11
Nov 14, 2025 15,900 866,800 54.52
Nov 7, 2025 29,400 925,500 31.48
Oct 31, 2025 16,700 926,300 55.47
Company Profile
SHIN NIPPON BIOMEDICAL LABORATORIES, LTD. is the domestic leader in preclinical testing services. The company offers services from basic research to contract testing, with a focus on pharmaceutical formulations. It is also involved in regenerative medicine.
Sector
Services
SHIN NIPPON BIOMEDICAL LABORATORIES, LTD. primarily operates in the CRO (Contract Research Organization) business, supporting pharmaceutical development. The company also engages in translational research, leveraging its proprietary nasal drug delivery technology and nurturing basic knowledge and technologies from universities and biotech ventures into viable businesses. Additionally, as part of its Medipolis project (a social benefit creation initiative), the company operates geothermal power generation and accommodation facilities utilizing its property in Ibusuki City, Kagoshima Prefecture.